These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11493453)

  • 41. In vitro immunization of patient T cells with autologous bone marrow antigen presenting cells pulsed with tumor lysates.
    Coulon V; Ravaud A; Gaston R; Delaunay M; Pariente JL; Verdier D; Scrivante V; Gualde N
    Int J Cancer; 2000 Dec; 88(5):783-90. PubMed ID: 11072249
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen.
    Cardoso AA; Schultze JL; Boussiotis VA; Freeman GJ; Seamon MJ; Laszlo S; Billet A; Sallan SE; Gribben JG; Nadler LM
    Blood; 1996 Jul; 88(1):41-8. PubMed ID: 8704200
    [TBL] [Abstract][Full Text] [Related]  

  • 43. B Cells Are the Dominant Antigen-Presenting Cells that Activate Naive CD4
    Hong S; Zhang Z; Liu H; Tian M; Zhu X; Zhang Z; Wang W; Zhou X; Zhang F; Ge Q; Zhu B; Tang H; Hua Z; Hou B
    Immunity; 2018 Oct; 49(4):695-708.e4. PubMed ID: 30291027
    [TBL] [Abstract][Full Text] [Related]  

  • 44. T cell competition for the antigen-presenting cell as a model for immunodominance in the cytotoxic T lymphocyte response against minor histocompatibility antigens.
    Grufman P; Wolpert EZ; Sandberg JK; Kärre K
    Eur J Immunol; 1999 Jul; 29(7):2197-204. PubMed ID: 10427982
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential susceptibility of naïve versus cloned CD4+ T cells to antigen-specific and MHC-restricted anergy induction.
    Liu QS; Zhang RH; Chu YW; Xiong SD
    Sheng Li Xue Bao; 2003 Dec; 55(6):633-40. PubMed ID: 14695478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Complementary role of CD4+ T cells and secondary lymphoid tissues for cross-presentation of tumor antigen to CD8+ T cells.
    Yu P; Spiotto MT; Lee Y; Schreiber H; Fu YX
    J Exp Med; 2003 Apr; 197(8):985-95. PubMed ID: 12695490
    [TBL] [Abstract][Full Text] [Related]  

  • 47. On the site and mode of antigen presentation for the initiation of clonal expansion of CD8 T cells specific for a natural tumor antigen.
    Bai XF; Gao JX; Liu J; Wen J; Zheng P; Liu Y
    Cancer Res; 2001 Sep; 61(18):6860-7. PubMed ID: 11559562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes.
    Fu TM; Ulmer JB; Caulfield MJ; Deck RR; Friedman A; Wang S; Liu X; Donnelly JJ; Liu MA
    Mol Med; 1997 Jun; 3(6):362-71. PubMed ID: 9234241
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A CD40/CD40L feedback loop drives the breakdown of CD8(+) T-cell tolerance following depletion of suppressive CD4(+) T cells.
    Muth S; Schütze K; Hain T; Yagita H; Schild H; Probst HC
    Eur J Immunol; 2014 Apr; 44(4):1099-107. PubMed ID: 24420080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Graft-host tolerance in bone marrow transplant chimeras. Absence of graft-versus-host disease is associated with unresponsiveness to minor histocompatibility antigens expressed by all tissues.
    Brochu S; Baron C; Bélanger R; Perreault C
    Blood; 1994 Nov; 84(9):3221-8. PubMed ID: 7949193
    [TBL] [Abstract][Full Text] [Related]  

  • 51. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
    J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4
    Lacher MD; Bauer G; Fury B; Graeve S; Fledderman EL; Petrie TD; Coleal-Bergum DP; Hackett T; Perotti NH; Kong YY; Kwok WW; Wagner JP; Wiseman CL; Williams WV
    Front Immunol; 2018; 9():776. PubMed ID: 29867922
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monitoring CD4+ T cell responses against viral and tumor antigens using T cells as novel target APC.
    Atanackovic D; Matsuo M; Ritter E; Mazzara G; Ritter G; Jäger E; Knuth A; Old LJ; Gnjatic S
    J Immunol Methods; 2003 Jul; 278(1-2):57-66. PubMed ID: 12957396
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dynamic imaging reveals promiscuous crosspresentation of blood-borne antigens to naive CD8+ T cells in the bone marrow.
    Milo I; Sapoznikov A; Kalchenko V; Tal O; Krauthgamer R; van Rooijen N; Dudziak D; Jung S; Shakhar G
    Blood; 2013 Jul; 122(2):193-208. PubMed ID: 23637125
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antigens expressed by myelinating glia cells induce peripheral cross-tolerance of endogenous CD8+ T cells.
    Schildknecht A; Probst HC; McCoy KD; Miescher I; Brenner C; Leone DP; Suter U; Ohashi PS; van den Broek M
    Eur J Immunol; 2009 Jun; 39(6):1505-15. PubMed ID: 19462379
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma.
    Chan JL; Tang KC; Patel AP; Bonilla LM; Pierobon N; Ponzio NM; Rameshwar P
    Blood; 2006 Jun; 107(12):4817-24. PubMed ID: 16493000
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Positive and negative selection of T cell repertoires during differentiation in allogeneic bone marrow chimeras.
    Onoé K; Gotohda T; Nishihori H; Aranami T; Iwabuchi C; Iclozan C; Morohashi T; Ogasawara K; Good RA; Iwabuchi K
    Transpl Immunol; 2003; 12(1):79-88. PubMed ID: 14551035
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sampling of complementing self-antigen pools by thymic stromal cells maximizes the scope of central T cell tolerance.
    Klein L; Roettinger B; Kyewski B
    Eur J Immunol; 2001 Aug; 31(8):2476-86. PubMed ID: 11500832
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modulation of graft-versus-host disease: role of regulatory T lymphocytes.
    Hess AD
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):13-21. PubMed ID: 16399597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunodominance deters the response to other tumor antigens thereby favoring escape: prevention by vaccination with tumor variants selected with cloned cytolytic T cells in vitro.
    Van Waes C; Monach PA; Urban JL; Wortzel RD; Schreiber H
    Tissue Antigens; 1996 May; 47(5):399-407. PubMed ID: 8795140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.